Oct 12 (Reuters) - Basilea Pharmaceutica AG BSLN.S :
* Announces that Health Canada approved Zevtera for
treatment of bacterial lung infections
Source text for Eikon: ID:nHUGb9fHtp
Further company coverage: BSLN.S
(Gdynia Newsroom)
Oct 12 (Reuters) - Basilea Pharmaceutica AG BSLN.S :
* Announces that Health Canada approved Zevtera for
treatment of bacterial lung infections
Source text for Eikon: ID:nHUGb9fHtp
Further company coverage: BSLN.S
(Gdynia Newsroom)